Balanced news tone
News Sentiment
BETA sentiment intelligence
BETA DRUGS LIMITED news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.
Price is moving more forcefully than the current news tone suggests.
83/100 classification confidence.
directly relevant articles
high-authority source matches
+13.2% over one week, +33.6% over four weeks, trend active, and materially above fair value.
Beta Drugs completes Nivian Lifesciences acquisition
Market Reaction
Price moving ahead of tone
Price is moving more forcefully than the current news tone suggests.
Sentiment Mix
Positive, neutral, negative
Relevance
Why the article matched
Sources
Coverage mix
Event Lens
What the news is about
Sentiment Trail
Score over time
News Tape
Relevant headlines
Beta Drugs completes Nivian Lifesciences acquisition
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 25 May 2026 07:00
- Source
- scanx.trade
Earnings Troubles May Signal Larger Issues for Beta Drugs (NSE:BETA) Shareholders
- Tone
- Neutral 50/100
- Event
- Earnings
- Published
- 22 May 2026 07:00
- Source
- simplywall.st
Beta Drugs Consolidated March 2026 Net Sales at Rs 93.96 crore, up 0.21% Y-o-Y
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- Moneycontrol.com
Beta Drugs Standalone March 2026 Net Sales at Rs 54.35 crore, up 1.14% Y-o-Y
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 14 May 2026 07:00
- Source
- Moneycontrol.com
Beta Drugs Achieves Regulatory Milestones in Azerbaijan and Philippines Markets
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 22 Apr 2026 07:00
- Source
- scanx.trade
Beta Drugs Acquires 66% Stake in IVF Specialist Nivian Lifesciences for ₹69.4 Crore
- Tone
- Neutral 50/100
- Event
- Deals and strategy
- Published
- 12 Jan 2026 08:00
- Source
- scanx.trade
Beta Drugs Ltd
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 10 Jan 2026 11:10
- Source
- Equitypandit
Beta Drugs Secures Mainboard Approval, Trading Begins Nov 24
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 21 Nov 2025 08:00
- Source
- HDFC Sky
Beta Drugs up 3% on approval to migrate shares from SME to mainboard
- Tone
- Neutral 50/100
- Event
- Regulatory and legal
- Published
- 21 Nov 2025 08:00
- Source
- Business Standard
Here's Why Beta Drugs Limited's (NSE:BETA) CEO May Deserve A Raise
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 24 Sep 2025 07:00
- Source
- simplywall.st
Beta Drugs Ltd. Share Price Today - Beta Drugs Ltd. Stock Price Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 21 Aug 2025 02:29
- Source
- CNBC TV18
Beta Drugs Limited raises INR 117 cr from HealthQuad, Inti Capital and others to accelerate growth plans
- Tone
- Positive 82/100
- Event
- Market update
- Published
- 02 Dec 2024 08:00
- Source
- ET CFO
Beta Drugs raises Rs 117 crore from HealthQuad
- Tone
- Positive 66/100
- Event
- Market update
- Published
- 27 Nov 2024 08:00
- Source
- The Economic Times
Fundamental Radar: Why is Beta Drugs a good play in the oncology space? Sandeep Raina explains
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 18 Dec 2023 08:00
- Source
- The Economic Times
Beta Drugs Ltd. Share Price Today | Beta Drugs Live NSE/BSE
- Tone
- Neutral 50/100
- Event
- Market update
- Published
- 24 Mar 2022 20:37
- Source
- Value Research